These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38100785)

  • 1. Valproic Acid-Associated Hyperammonemia: A Systematic Review-Reply to Comments by Dr Aney.
    Wong YJ; Mihic T; Wan A; Fan J; Gnyra M
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):73-74. PubMed ID: 38100785
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic Acid-Associated Hyperammonemia: A Systematic Review. Comments on the Article by Dr Wong and Colleagues.
    Aney J
    J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):73. PubMed ID: 38100784
    [No Abstract]   [Full Text] [Related]  

  • 3. Ammonemia in bipolar patients on maintenance treatment with valproic acid.
    Bocchetta A; Siddu A; Sardu C; Sarnicola A; Martinelli V
    J Clin Psychopharmacol; 2012 Feb; 32(1):148-50. PubMed ID: 22217957
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A; Haddad R; Naja WJ
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole-related hyponatremia and consequent valproic acid-related hyperammonemia in one patient.
    Lin MW; Chang C; Yeh CB; Tai YM; Chang HA; Kao YC; Tzeng NS
    Aust N Z J Psychiatry; 2017 Mar; 51(3):296-297. PubMed ID: 27694641
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperammonemia due to valproic acid in the psychiatric setting.
    Carr RB; Shrewsbury K
    Am J Psychiatry; 2007 Jul; 164(7):1020-7. PubMed ID: 17606652
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe acute hyperammonemia after brief exposure to valproate.
    Eubanks AL; Aguirre B; Bourgeois JA
    Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of hyperammonemic encephalopathy after 11 years of valproate therapy.
    Stewart JT
    J Clin Psychopharmacol; 2008 Jun; 28(3):361-2. PubMed ID: 18480705
    [No Abstract]   [Full Text] [Related]  

  • 10. [A severe, reversible encephalopathy after prolonged use of valproic acid].
    van Haaren PCF; Bloemkolk D; Rundervoort RS; Gerritse FL
    Tijdschr Psychiatr; 2023; 65(1):50-53. PubMed ID: 36734691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bipolar disorder and valproate-induced hyperammonemic encephalopathy in an adolescent with diabetes.
    Young L; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):449-52. PubMed ID: 20973717
    [No Abstract]   [Full Text] [Related]  

  • 12. A case of hyperammonaemic encephalopathy due to valproic acid.
    Prins MC; van Meijel JJ
    Neth J Med; 2011 Sep; 69(9):389-91. PubMed ID: 21978982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperammonaemic encephalopathy due to valproic acid in the neonatal period].
    Jiménez-Parrilla F; Pérez-Sánchez A; Núñez-Solís JM; Madruga-Garrido M; Losada-Martínez A
    Rev Neurol; 2009 Jun 1-15; 48(11):613-4. PubMed ID: 19472163
    [No Abstract]   [Full Text] [Related]  

  • 14. Valproate-induced reversible pseudoatrophy of the brain and hyperammonemic encephalopathy in a bipolar patient.
    Abreu LN; Issler C; Lafer B
    Aust N Z J Psychiatry; 2009 May; 43(5):484-5. PubMed ID: 19382315
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible Encephalopathy due to Valproic Acid Induced Hyperammonemia in a Patient with Bipolar I Disorder: A Cautionary Report.
    Patel N; Landry KB; Fargason RE; Birur B
    Psychopharmacol Bull; 2017 Jan; 47(1):40-44. PubMed ID: 28138203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hyperammonemia secondary to the use of valproic acid: case report].
    Turcato Mde F; Fernandes RM; Wichert-Ana L; Funayama CA
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):364-6. PubMed ID: 16100994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid-induced hyperammonemia: a case report.
    McCall M; Bourgeois JA
    J Clin Psychopharmacol; 2004 Oct; 24(5):521-6. PubMed ID: 15349008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate-related hyperammonemic encephalopathy: report of 1 case.
    Selvi Y; Annagur BB; Sayin AA; Akbaba N
    J Clin Psychopharmacol; 2014 Jun; 34(3):e1. PubMed ID: 24633004
    [No Abstract]   [Full Text] [Related]  

  • 19. Cognitive side effects of valproic acid-induced hyperammonemia in children with epilepsy.
    Nicolai J; Aldenkamp AP; Huizenga JR; Teune LK; Brouwer OF
    J Clin Psychopharmacol; 2007 Apr; 27(2):221-4. PubMed ID: 17414255
    [No Abstract]   [Full Text] [Related]  

  • 20. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting.
    Kimmel RJ; Irwin SA; Meyer JM
    Int Clin Psychopharmacol; 2005 Jan; 20(1):57-8. PubMed ID: 15602119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.